Align Technology (ALGN) Baird's 2024 Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Baird's 2024 Global Healthcare Conference summary
21 Jan, 2026Market environment and growth outlook
Global orthodontics market remains stable, with regional variations tied to inflation and interest rates; Southeast Asia, Latin America, and the Middle East are performing better than others.
Teen segment is less discretionary and offers significant growth potential, as only 30% of cases are teens versus 75% in the general market.
Adult market growth is expected to be slower than teens but should outpace the overall industry once macroeconomic conditions improve.
There are 500-600 million potential adult patients with malocclusion, indicating long-term demand.
Teen market is projected to grow at double-digit rates when macro conditions normalize.
Product innovation and adoption
Invisalign Palatal Expander (IPE) targets 15-20% of teen cases, with initial adoption in North America and ANZ; expansion to more countries is planned.
IPE is priced at $500, offering flexibility and technological advantages over traditional metal devices.
The palatal expansion market is estimated at $1.5 billion, with expectations to capture 10-20% share in the next few years.
Doctors are seeking combined solutions (phase one and two) for skeletal expansion and teeth straightening.
New iTero Lumina scanner with NIRI technology is approved and positioned for further growth in both ortho and restorative markets.
Pricing, ASP trends, and financial strategies
Global ASP declined just over 5% year-over-year, with $22 of the $40 drop due to currency and $8 due to UK VAT changes.
Remaining ASP pressure is attributed to increased sales to new submitters and lower-stage cases, which are gross margin accretive.
ASP is expected to remain flat to slightly down, consistent with historical trends.
Doctor Subscription Program (DSP) has grown from 1% to 4% of case volume, with potential for further growth as it expands internationally.
DSP and leasing models for iTero scanners help doctors manage cash flow and are gross margin accretive, supporting broader adoption.
Latest events from Align Technology
- Broad-based growth, strong DSO performance, and stable outlook drive confidence for 2026.ALGN
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Strong growth in Europe and APAC, with product innovation and efficiency boosting margins.ALGN
Leerink Global Healthcare Conference 202610 Mar 2026 - Record Q4 and FY2025 results, robust Clear Aligner growth, and strong 2026 outlook.ALGN
Q4 20254 Feb 2026 - Digital dentistry expansion, AI-driven innovation, and global growth drive strong financial outlook.ALGN
Investor Day 20253 Feb 2026 - Q2 2024 revenue up 2.6% to $1.03B; margin pressured by FX, mix, and legal settlement.ALGN
Q2 20243 Feb 2026 - Q1 2024 growth fueled by AI, 3D printing, and new digital orthodontic products.ALGN
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Raised guidance and new products drive growth, margin expansion, and digital adoption.ALGN
Jefferies Global Healthcare Conference31 Jan 2026 - Q3 revenue rose 1.8% year-over-year to $977.9M; restructuring and $275M buyback announced.ALGN
Q3 202419 Jan 2026 - Growth investments, digital innovation, and global expansion drive recovery and future margin gains.ALGN
UBS Global Healthcare Conference 202414 Jan 2026